article Articles

Sanofi’s Zerhouni Advocates for Integrated Drug Development Model

Elias Zerhouni, MD of Sanofi, painted a picture of an integrated and innovative drug discovery process for attendees of BioForward’s event.

A Closer Look at the ‘Cost of Doing Business’

Karen Olson, a former site director, shares insight into some hidden costs to consider when calculating the cost of doing business.

Site Selection for Sponsored Trials: How You Can Rank at the Top

The Hoosier Oncology Group, a leading CRO, shares tips for setting your research institution apart from the rest and becoming a “go-to” site.

Forte Celebrates Record Year for OnCore Enterprise Research System

Nine leading clinical research institutions selected the OnCore Enterprise Research system in 2012 to manage their clinical trial operations.

Disclosure Requirements for ClinicalTrials.gov: Your FAQs Answered (Part 2)

Barbara Godlew, of The FAIRE Company, LLC, answers your questions related to ClinicalTrials.gov. This is the second part of a two-part series.

CTMS and EMR Software: Why Integration is Necessary

It must be an industry priority to collaborate in order to integrate electronic health record systems with clinical trial management systems.

Subject Reimbursement in Clinical Trials: When and How?

Trial participants often complete things that likely would not be requested with routine care. When and how to compensation subjects is often debated.

Is Now the Right Time for a CTMS?

There may be a number of reasons you’re looking for a CTMS. Before you get too far along in the process, make sure that now is the right time.

Consortia in Clinical Trials: Do the Benefits Outweigh the Challenges?

The concept of conducting clinical trials in a consortium is gaining greater prominence in the industry. Beverly Ginsburg-Cooper, Senior VP for Research at Dana-Farber Cancer Institute, discusses the benefits and lessons learned at the Dana-Farber/Harvard Cancer Center.

Disclosure Requirements for ClinicalTrials.gov: Your FAQs Answered (Part 1)

Barbara Godlew, President of The FAIRE Company, answers your questions on disclosure requirements for ClinicalTrials.gov. Part 1 of a 2-part series.

Patient Retention: Minimize Dropout Rates Simply and Effectively

Since recruitment alone can be a long, tedious, and costly activity, it is critical that enrolled subjects maintain their participation for the duration of the trial.

How Can a Clinical Trial Management System Benefit You?

Lower costs, increase productivity, and manage time

1 49 50 51 52